"L'IUCT Oncopole est composé de l'Institut Claudius Regaud, centre de lutte contre le cancer et de plusieurs équipes du CHU de Toulouse. Sur un même site, les deux établissements réunissent l'expertise de 1500 professionnels spécialisés en cancérologie. L'Institut est situé au cœur d'un campus regroupant des acteurs privés et publics investis dans la lutte contre le cancer. Trois missions lui sont confiées : le soin, la recherche et l'enseignement."

During the past decade, Pole IUC Oncopole CHU conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pole IUC Oncopole CHU" #1 collaborator was "Legend Biotech" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Pole IUC Oncopole CHU" are "Hematological Malignancies" (2 trials), "Multiple Myeloma" (2 trials), "Newly Diagnosed Multiple Myeloma" (1 trials) and "Relapsed/Refractory Multiple Myeloma" (1 trials). Many other conditions were trialed in "Pole IUC Oncopole CHU" in a lesser frequency.

Most popular intervention types in "Pole IUC Oncopole CHU" are "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (2 trials), "No intervention" (2 trials), "Teclistamab" (2 trials), "Bortezomib" (1 trials) and "Daratumumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pole IUC Oncopole CHU" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Pole IUC Oncopole CHU". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Pole IUC Oncopole CHU, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pole IUC Oncopole CHU, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".